Author:
Liu Qingxia,Song Qifeng,Luo Cheng,Wei Jian,Xu Yao,Zhao Liwen,Wang Yong
Subject
Molecular Biology,Immunology
Reference41 articles.
1. Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma;Abou-Alfa;J. Hepatol.,2016
2. GPC3-targeted CAR-T cells secreting B7H3-targeted BiTE exhibit potent cytotoxicity activity against hepatocellular carcinoma cell in the in vitro assay;Cao;Biochem Biophys. Rep.,2022
3. The development and improvement of immunodeficient mice and humanized immune system mouse models;Chen;Front Immunol.,2022
4. Natural killer cells: the next wave in cancer immunotherapy;Chen;Front Immunol.,2022
5. Trispecific killer engager 161519 enhances natural killer cell function and provides anti-tumor activity against CD19-positive cancers;Cheng;Cancer Biol. Med.,2020